![Expert Q&A: Adapting to the Expanding Market of At-Home Testing](https://www.g2intelligence.com/wp-content/uploads/2024/01/Feb24.CDI_.ExpertQA.WilliamGFinn.BK-iStock-1384699746-1100x800-1-1080x675.jpg)
Expert Q&A: Adapting to the Expanding Market of At-Home Testing
Medical director William G. Finn, MD, discusses key trends, challenges, and opportunities related to the expansion of at-home testing.
Medical director William G. Finn, MD, discusses key trends, challenges, and opportunities related to the expansion of at-home testing.
A brief overview of antimicrobial susceptibility testing, current methods used, and new methods on the horizon.
Genomic epidemiology can provide insights into pathogen transmission and evolution—and facilitate better countermeasures against infectious disease.
Recent developments pose reimbursement and compliance challenges for billing and coding infectious disease testing—here’s how to manage them.
AAV2 virus detected with metagenomics, TE sequencing, and PCR in non-A–E hepatitis cases from two cohorts in Scotland/the UK and the US.